ELN — Elanix Biotechnologies AG Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- €0.43m
- €0.39m
- €0.06m
Brief: Elanix Biotechnologies: Vice Chairman Of Supervisory Board Fang Bao Resigns
Brief: BaFin Says Imposed Fines Of 150,000 Euros Against Elanix Biotechnologies
Brief: BaFin Says Imposed Coercive Fines On Elanix Biotechnologies
Brief: BaFin Says Disciplinary Fine Of 250,000 Euros Imposed Against Elanix Biotechnologies
Brief: BaFin Threatens Elanix Biotechnologies With Coercive Fines Of EUR 565,000
Brief: Elanix Biotechnologies Says Criminal Charges Filed Against Former CEO Thomas J. Svoboda
Brief: Elanix Biotechnologies: Anja Silling To Become Chairman Of Supervisory Board
Brief: Elanix Biotechnologies FY EBIT loss narrows to 2.7 million euros
Brief: Elanix Biotechnologies says capital increase successfully placed
Brief: Elanix Biotechnologies initiates cash capital increase
Brief: Elanix Biotechnologies: CEO informs about planned cash capital increase
Brief: Elanix Biotechnologies announces non-binding letter of intent with Oxford MEStar Ltd
Brief: Elanix Biotechnologies decides on capital increase
Brief: Elanix Biotechnologies decides on capital increase
Brief: Elanix Biotechnologies announces changes to supervisory board
Brief: Porta Systems operates now as elanix Biotechnologies AG
Brief: Porta Systems says AGM creates conditions for reorientation as biotechnology company
Brief: Porta Systems H1 net loss narrows to EUR 4,106
Brief: Porta Systems FY net loss narrows to 15,000 euros